Seeking Alpha
 

Medtronic Inc. (MDT)

- NYSE
  • Sep. 28, 2012, 5:41 AM
    Medtronic (MDT) agrees to pay $816M for China Kanghui, a provider of orthopedic implants in a deal that expands the U.S. company's presence in China. Medtronic's offer of $30.75/ADR represents a 22.5% premium to Kanghui close yesterday. Barclays analyst Jason Mann says Kanghui provides Medtronic with "access to thousands of hospitals...(in) the fastest growing orthopedic market." (PR)
    | Comment!
  • Sep. 26, 2012, 7:56 AM
    The EU proposes tougher standards on medical devices and implants after investigations showed hundreds of thousands of women were at risk from substandard silicone implants. Independent assessment of manufacturers and increased product testing could result from the new legislation.
    | 4 Comments
  • Sep. 18, 2012, 11:58 AM
    An Appeals court has overturned a lower court ruling that found Medtronic (MDT +0.2%) did not infringe on Boston Scientific (BSX -1.4%) CRT patents, and has remanded the case for further proceedings. The appeals court says the lower court relied on a "legally incorrect allocation of the burden of proof" and incorrectly construed the claim terms in the suit.
    | Comment!
  • Aug. 27, 2012, 8:38 AM
    Medtronic's (MDT) Protect study confirms the long-term safety of drug-eluting coronary stents, which slowly release a drug to block cell proliferation. The trial, the largest ever for such products, used Medtronic's Endeavor stent and J&J's (JNJ) Cypher to test for stent thrombosis, when a blood clot forms inside the stent. (PR)
    | 4 Comments
  • Aug. 24, 2012, 1:32 PM
    Medtronic (MDT +0.3%) receives FDA and CE Mark approval for its Arctic Front Advance cardiac cryoballoon for the treatment of paroxysmal atrial fibrillation. MDT has the only cryoballoon system currently on the market worldwide, which is purported to provide a more efficient approach to treating the condition than through point-by-point, radiofrequency ablation.
    | Comment!
  • Aug. 21, 2012, 9:17 AM
    Medtronic's (MDT) business for neuromodulation devices received an FDA warning letter related mainly to the company's processes for handling complaints, MDT CFO Gary Ellis disclosed in a conference call, adding that he does not expect a material impact on financial results. (earlier: FQ1 results)
    | Comment!
  • Aug. 21, 2012, 7:49 AM
    More on Medtronic (MDT -3.1%) FQ1: net profit +5.2% to $864M; net revenues +5% on constant currency basis after adjusting for a $119M negative forex impact. Reiterates FY 2013 EPS guidance of $3.62-$3.70 vs. consensus of $3.66. International revenue +6% and accounts for 44% of the total. Emerging market +14% "Growth was broad-based across businesses and geographies." (PR)
    | Comment!
  • Aug. 21, 2012, 7:20 AM
    Medtronic (MDT): FQ1 EPS of $0.83 misses by $0.02. Revenue of $4B in-line. (PR)
    | Comment!
  • Aug. 21, 2012, 12:05 AM
    Notable earnings before Tuesday’s open: BBY, BKS, MDT, TSL
    | Comment!
  • Aug. 20, 2012, 5:30 PM
    Notable earnings before Tuesday’s open: BBY, BKS, MDT, TSL
    | Comment!
  • Aug. 13, 2012, 9:51 AM
    Medtronic (MDT -0.45%) has said it intends to increase its presence in China through acquisitions, making it the first foreign medical-equipment multinational to announce such a strategy. However, Medtronic may face difficulties in finding companies to buy, says a local business official, due to local R&D capabilities, branding, quality control and staff training.
    | Comment!
  • Jun. 28, 2012, 11:32 AM
    The Supreme Court opinion on the Healthcare Act means that medical device makers still face a 2.3% tax on domestic sales starting next year unless they can persuade Congress to repeal it. Shares are sliding: MDT -1.2%, BSX -2.7%, STJ -1%, EW 1.1%, SYK -1.9%, ATRC -4.7%, CYBX -1.6%.
    | 1 Comment
  • Jun. 28, 2012, 10:21 AM
    More on the Supreme Court healthcare opinion: The court reinforces that individuals can simply refuse to comply with the mandate, and pay the tax. The Supreme Court's live blog is here.
    | 30 Comments
  • Jun. 28, 2012, 10:13 AM
    More on the Supreme Court healthcare opinion: The bottom line: the entire ACA is upheld, with the exception that the federal government's power to terminate states' Medicaid funds is narrowly read. The Supreme Court's live blog is here.
    | Comment!
  • Jun. 28, 2012, 10:11 AM
    More on the Supreme Court healthcare opinion: The Medicaid provision is limited but not invalidated.
    | Comment!
  • Jun. 28, 2012, 10:10 AM
    The Supreme Court healthcare opinion: The individual mandate survives as a tax. You can read the full opinion here.
    | 88 Comments
Visit Seeking Alpha's
MDT vs. ETF Alternatives
Company Description
Medtronic PLC is engaged in providing medical technology alleviating pain, restoring health, and extending life of people. It currently functions in three operating segments that manufacture and sell device-based medical therapies.